1996
DOI: 10.3109/00498259609046748
|View full text |Cite
|
Sign up to set email alerts
|

Disposition of the opioid antagonist, nalmefene, in rat and dog

Abstract: 1. The disposition of nalmefene in rat and dog was studied using in vitro and in vivo methodology. In vitro metabolite profiles were obtained following incubation of nalmefene with liver microsomes and biological fluids were assayed to profile in vivo metabolites. Characterization of metabolites was accomplished using hplc, co-chromatography with synthetic standards, or LC/MS. 2. In rat, tissue distribution and metabolite plasma concentration-time data were obtained following intravenous bolus dosing of nalmef… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0

Year Published

2005
2005
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 10 publications
0
11
0
Order By: Relevance
“…A few cases were previously reported. Diglucuronides were identified as the metabolites of morphinan and nalmefene,13, 14 and diglucuronide and bisglucuronide conjugates were identified as estradiol and estriol metabolites in dog liver microsomes 15. More recently, diglucuronides of some endogenous steroids were isolated and identified as in vivo metabolites in dogs 16…”
Section: Resultsmentioning
confidence: 99%
“…A few cases were previously reported. Diglucuronides were identified as the metabolites of morphinan and nalmefene,13, 14 and diglucuronide and bisglucuronide conjugates were identified as estradiol and estriol metabolites in dog liver microsomes 15. More recently, diglucuronides of some endogenous steroids were isolated and identified as in vivo metabolites in dogs 16…”
Section: Resultsmentioning
confidence: 99%
“…Quite interestingly, however, another type of glucuronide, referred here as a diglucuronide, has been reported in the case of nalmefene, a narcotic antagonist excreted mainly as nalmefene 3-O-diglucuronide in the urine after administration to dogs, where glucuronidation occurred in duplicate at a single functional group of aglycone. 6,7) This novel diglucuronide has a chemical structure where the second glucuronosyl group is connected directly to the 2?-hydroxyl group of theˆrst glucuronic acid moiety that is conjugated to the 3-hydroxyl group of nalmefene. After publication of the diglucuronide of nalmefene formed in vivo, weˆrst reported that 4-hydroxybiphenyl Odiglucuronide is produced in vitro from 4-hydrox- ybiphenyl by dog liver microsomes but not by rat, monkey or human liver microsomes, and showed that the monoglucuronide serves as the next substrate for further glucuronidation.…”
Section: Introductionmentioning
confidence: 99%
“…Glucuronidation reaction could proceed on another functional group of monoglucuronide leading to bisglucuronides (BGs) or diglucuronides . In the first type, two separated functional groups on the same molecule are conjugated with glucuronic acid, whereas in the other, glucuronidation occurred two times at a single functional group of the aglycone …”
Section: Introductionmentioning
confidence: 99%